Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19

Detalles Bibliográficos
Autores principales: Gautret, Philippe, Lagier, Jean-Christophe, Honoré, Stéphane, Hoang, Van Thuan, Raoult, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779282/
https://www.ncbi.nlm.nih.gov/pubmed/33408033
http://dx.doi.org/10.1016/j.ijantimicag.2020.106242
_version_ 1783631301515935744
author Gautret, Philippe
Lagier, Jean-Christophe
Honoré, Stéphane
Hoang, Van Thuan
Raoult, Didier
author_facet Gautret, Philippe
Lagier, Jean-Christophe
Honoré, Stéphane
Hoang, Van Thuan
Raoult, Didier
author_sort Gautret, Philippe
collection PubMed
description
format Online
Article
Text
id pubmed-7779282
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd and International Society of Antimicrobial Chemotherapy.
record_format MEDLINE/PubMed
spelling pubmed-77792822021-01-04 Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19 Gautret, Philippe Lagier, Jean-Christophe Honoré, Stéphane Hoang, Van Thuan Raoult, Didier Int J Antimicrob Agents Letter to the Editor Elsevier Ltd and International Society of Antimicrobial Chemotherapy. 2021-01 2021-01-04 /pmc/articles/PMC7779282/ /pubmed/33408033 http://dx.doi.org/10.1016/j.ijantimicag.2020.106242 Text en © 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Gautret, Philippe
Lagier, Jean-Christophe
Honoré, Stéphane
Hoang, Van Thuan
Raoult, Didier
Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
title Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
title_full Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
title_fullStr Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
title_full_unstemmed Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
title_short Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
title_sort clinical efficacy and safety profile of hydroxychloroquine and azithromycin against covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779282/
https://www.ncbi.nlm.nih.gov/pubmed/33408033
http://dx.doi.org/10.1016/j.ijantimicag.2020.106242
work_keys_str_mv AT gautretphilippe clinicalefficacyandsafetyprofileofhydroxychloroquineandazithromycinagainstcovid19
AT lagierjeanchristophe clinicalefficacyandsafetyprofileofhydroxychloroquineandazithromycinagainstcovid19
AT honorestephane clinicalefficacyandsafetyprofileofhydroxychloroquineandazithromycinagainstcovid19
AT hoangvanthuan clinicalefficacyandsafetyprofileofhydroxychloroquineandazithromycinagainstcovid19
AT raoultdidier clinicalefficacyandsafetyprofileofhydroxychloroquineandazithromycinagainstcovid19

Ejemplares similares